Schrodinger, Inc. (SDGR) Financial Statements (2026 and earlier)

Company Profile

Business Address 1540 BROADWAY
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments352,124463,003451,087576,479642,691
Cash and cash equivalent147,326155,31590,474120,267202,296
Short-term investments204,798307,688360,613456,212440,395
Restricted cash and investments15,3315,7515,2433,000500
Receivables235,69265,99255,95331,74431,423
Prepaid expense12,2059,9268,5695,0304,409
Other undisclosed current assets19,64123,12413,1378,8073,955
Total current assets:634,993567,796533,989625,060682,978
Noncurrent Assets
Operating lease, right-of-use asset111,883117,778105,98275,38410,129
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization(20,854)(18,150)14,24410,0255,140
Long-term investments and receivables43,20883,25125,68343,16745,664
Long-term investments43,20883,25125,68343,16745,664
Intangible asset, including goodwill, after accumulated amortization4,7914,7915,378  
Goodwill4,7914,7914,791  
Intangible asset, excluding goodwill, after accumulated amortization   587  
Other noncurrent assets4,1556,0143,3112,8512,352
Other undisclosed noncurrent assets45,05041,475   
Total noncurrent assets:188,233235,159154,598131,42763,285
TOTAL ASSETS:823,226802,955688,587756,487746,263
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities63,04860,57439,86233,80123,259
Employee-related liabilities18,40512,000
Accounts payable10,66616,8159,4708,0798,398
Accrued liabilities52,38243,75930,3927,3172,861
Deferred revenue111,94456,23157,93155,36845,403
Other undisclosed current liabilities16,75516,86811,0062,0424,543
Total current liabilities:191,747133,673108,79991,21173,205
Noncurrent Liabilities
Long-term debt and lease obligation:    77,8277,221
Liabilities, other than long-term debt210,034120,724131,88330,36441,818
Deferred revenue108,8149,04325,59830,06441,164
Other liabilities146667800300654
Operating lease, liability101,074111,014105,48577,8277,221
Total noncurrent liabilities:210,034120,724131,883108,19149,039
Total liabilities:401,781254,397240,682199,402122,244
Equity
Equity, attributable to parent, including:421,445548,558447,894557,071624,015
Common stock     607
Additional paid in capital946,037885,973828,700786,964752,558
Accumulated other comprehensive income (loss)220281(2,382)(651)317
Accumulated deficit(525,541)(338,418)(379,138)(229,952)(129,559)
Other undisclosed equity, attributable to parent72972271471092
Equity, attributable to noncontrolling interest   11144
Total equity:421,445548,558447,905557,085624,019
TOTAL LIABILITIES AND EQUITY:823,226802,955688,587756,487746,263

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues207,539216,666180,955137,931108,095
Gain on disposition of assets for financial service operations  147,213   
Cost of revenue(75,456)(75,974)(79,933)(72,311)(44,623)
Gross profit:132,083140,692101,02265,62063,472
Operating expenses(341,379)(318,140)(247,839)(177,063)(124,388)
Operating loss:(209,296)(177,448)(146,817)(111,443)(60,916)
Nonoperating income (expense)23,585220,367(2,309)10,63534,624
Other nonoperating income17,90219,6933,950  
Other undisclosed income from continuing operations before equity method investments, income taxes     2,174
Income (loss) from continuing operations before equity method investments, income taxes:(185,711)42,919(149,126)(100,808)(24,118)
Income (loss) from equity method investments  147,21311,825(1,781)4,108
Other undisclosed income (loss) from continuing operations before income taxes  (147,213)(11,825)1,781(6,282)
Income (loss) from continuing operations before income taxes:(185,711)42,919(149,126)(100,808)(26,292)
Income tax expense(1,412)(2,199)(63)(411)(345)
Income (loss) from continuing operations:(187,123)40,720(149,189)(101,219)(26,637)
Loss before gain (loss) on sale of properties:(101,219)(26,637)
Net income (loss):(187,123)40,720(149,189)(101,219)(26,637)
Net income attributable to noncontrolling interest   38262,174
Net income (loss) available to common stockholders, diluted:(187,123)40,720(149,186)(100,393)(24,463)

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(187,123)40,720(149,189)(101,219)(26,637)
Comprehensive income (loss):(187,123)40,720(149,189)(101,219)(26,637)
Comprehensive income, net of tax, attributable to noncontrolling interest   38262,174
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(61)2,663(1,731)(968)301
Comprehensive income (loss), net of tax, attributable to parent:(187,184)43,383(150,917)(101,361)(24,162)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: